Literature DB >> 33083522

Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life.

Indu Subramanian1,2, Joshua Farahnik3, Laurie K Mischley3,4.   

Abstract

Social isolation and its deleterious effects on health increases with age in the general population. People with Parkinson's Disease (PWP) are no exception. Social isolation is a risk factor for worsened health outcomes and increased mortality. Symptoms such as depression and sleep dysfunction are adversely affected by loneliness. There is a paucity of research on social isolation in Parkinson's disease (PD), which is all the more critical now in the setting of social distancing due to COVID-19. The goal of this study was to survey individuals with PD to evaluate whether social isolation is associated with PD symptom severity and quality of life. Only individuals reporting a diagnosis of idiopathic PD were included in this analysis. The primary outcome measures were the Patient-Reported Outcomes in PD (PRO-PD) and questions from PROMIS Global related to social health. PRO-PD scores increased as social performance and social satisfaction scores diminished. Individuals who reported being lonely experienced a 55% greater symptom severity than those who were not lonely (P < 0.01). Individuals who documented having a lot of friends had 21% fewer symptoms than those with few or no friends (P < 0.01). Social isolation was associated with greater patient-reported PD severity and lower quality of life, although it is unclear whether this is the cause and/or a consequence of the disease. In essence, the Parkinson pandemic and the pandemic of social isolation have been further compounded by the recent COVID-19 pandemic. The results emphasize the need to keep PWP socially connected and prevent loneliness in this time of social distancing. Proactive use of virtual modalities for support groups and social prescribing should be explored. © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020.

Entities:  

Keywords:  Human behaviour; Parkinson's disease; Risk factors

Year:  2020        PMID: 33083522      PMCID: PMC7545190          DOI: 10.1038/s41531-020-00128-9

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  43 in total

1.  Social isolation, loneliness and health among older adults.

Authors:  Caitlin E Coyle; Elizabeth Dugan
Journal:  J Aging Health       Date:  2012-09-23

2.  Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease.

Authors:  K H Karlsen; J P Larsen; E Tandberg; J G Maeland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

3.  The Parkinson Pandemic-A Call to Action.

Authors:  E Ray Dorsey; Bastiaan R Bloem
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

Review 4.  Aerobic Exercise: Evidence for a Direct Brain Effect to Slow Parkinson Disease Progression.

Authors:  J Eric Ahlskog
Journal:  Mayo Clin Proc       Date:  2018-03       Impact factor: 7.616

5.  Comparative study of PROMIS self-efficacy for managing chronic conditions across chronic neurologic disorders.

Authors:  Lisa M Shulman; Craig Velozo; Sergio Romero; Ann L Gruber-Baldini
Journal:  Qual Life Res       Date:  2019-03-26       Impact factor: 4.147

Review 6.  A meta-analysis of interventions to reduce loneliness.

Authors:  Christopher M Masi; Hsi-Yuan Chen; Louise C Hawkley; John T Cacioppo
Journal:  Pers Soc Psychol Rev       Date:  2010-08-17

Review 7.  Evolutionary mechanisms for loneliness.

Authors:  John T Cacioppo; Stephanie Cacioppo; Dorret I Boomsma
Journal:  Cogn Emot       Date:  2013-09-25

8.  Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middle-aged men and women.

Authors:  Andrew Steptoe; Natalie Owen; Sabine R Kunz-Ebrecht; Lena Brydon
Journal:  Psychoneuroendocrinology       Date:  2004-06       Impact factor: 4.905

9.  Patient-reported outcomes: A new era in clinical research.

Authors:  Prasanna R Deshpande; Surulivel Rajan; B Lakshmi Sudeepthi; C P Abdul Nazir
Journal:  Perspect Clin Res       Date:  2011-10

10.  Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet Neurol       Date:  2017-09-17       Impact factor: 44.182

View more
  21 in total

1.  Spotlight on non-motor symptoms and Covid-19.

Authors:  Silvia Rota; Iro Boura; Yi-Min Wan; Claudia Lazcano-Ocampo; Mayela Rodriguez-Violante; Angelo Antonini; Kallol Ray Chaudhuri
Journal:  Int Rev Neurobiol       Date:  2022-07-09       Impact factor: 4.280

2.  Parkinson's disease and Covid-19: The effect and use of telemedicine.

Authors:  Aleksandra M Podlewska; Daniel J van Wamelen
Journal:  Int Rev Neurobiol       Date:  2022-07-14       Impact factor: 4.280

3.  Impact of the COVID-19 pandemic on physical activity, anxiety, and depression in patients with Parkinson's disease.

Authors:  Birgul Balci; Burcin Aktar; Sinan Buran; Melike Tas; Berril Donmez Colakoglu
Journal:  Int J Rehabil Res       Date:  2021-06-01       Impact factor: 1.832

4.  Falls Prevention and Quality of Life Improvement by Square Stepping Exercise in People with Parkinson's Disease: Project Report.

Authors:  Asunción Mayoral-Moreno; Carlos Alexis Chimpén-López; Laura Rodríguez-Santos; María Isabel Ramos-Fuentes; Francisco José Vaz-Leal; Manuel Alfredo Moral; Jorge Pérez-Gómez; José Carmelo Adsuar
Journal:  J Pers Med       Date:  2021-04-30

5.  Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives.

Authors:  Zachary A Macchi; Roman Ayele; Megan Dini; Jensine Lamira; Maya Katz; Steven Z Pantilat; Jacqueline Jones; Benzi M Kluger
Journal:  Palliat Med       Date:  2021-05-18       Impact factor: 5.713

Review 6.  How COVID-19 will boost remote exercise-based treatment in Parkinson's disease: a narrative review.

Authors:  Agnes Langer; Lucia Gassner; Anna Flotz; Sebastian Hasenauer; Jakob Gruber; Laurenz Wizany; Rochus Pokan; Walter Maetzler; Heidemarie Zach
Journal:  NPJ Parkinsons Dis       Date:  2021-03-08

7.  Parkinson's disease patients' needs during the COVID-19 pandemic in a red zone: A framework analysis of open-ended survey questions.

Authors:  Francesco Cavallieri; Francesca Sireci; Valentina Fioravanti; Giulia Toschi; Vittorio Rispoli; Francesca Antonelli; Massimo Costantini; Luca Ghirotto; Franco Valzania
Journal:  Eur J Neurol       Date:  2021-02-06       Impact factor: 6.288

8.  Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan.

Authors:  Fukiko Kitani-Morii; Takashi Kasai; Go Horiguchi; Satoshi Teramukai; Takuma Ohmichi; Makiko Shinomoto; Yuzo Fujino; Toshiki Mizuno
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

9.  Self-Perceived Life Satisfaction during the First Wave of the COVID-19 Pandemic in Sweden: A Cross-Sectional Study.

Authors:  Christina Brogårdh; Catharina Sjödahl Hammarlund; Frida Eek; Kjerstin Stigmar; Ingrid Lindgren; Anna Trulsson Schouenborg; Eva Ekvall Hansson
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

10.  Secondary Impact of COVID-19 Pandemic on People with Parkinson's Disease-Results of a Polish Online Survey.

Authors:  Karolina Krzysztoń; Beata Mielańczuk-Lubecka; Jakub Stolarski; Anna Poznańska; Katarzyna Kępczyńska; Agata Zdrowowicz; Izabela Domitrz; Jan Kochanowski
Journal:  Brain Sci       Date:  2021-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.